JP2015500285A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015500285A5 JP2015500285A5 JP2014545981A JP2014545981A JP2015500285A5 JP 2015500285 A5 JP2015500285 A5 JP 2015500285A5 JP 2014545981 A JP2014545981 A JP 2014545981A JP 2014545981 A JP2014545981 A JP 2014545981A JP 2015500285 A5 JP2015500285 A5 JP 2015500285A5
- Authority
- JP
- Japan
- Prior art keywords
- oral spray
- spray formulation
- formulation
- sildenafil
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000009472 formulation Methods 0.000 claims 33
- 239000000203 mixture Substances 0.000 claims 33
- 229940041678 oral spray Drugs 0.000 claims 26
- 239000000668 oral spray Substances 0.000 claims 26
- 238000000034 method Methods 0.000 claims 25
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 claims 19
- 229960003310 sildenafil Drugs 0.000 claims 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 239000002535 acidifier Substances 0.000 claims 2
- 230000003113 alkalizing effect Effects 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000004064 dysfunction Effects 0.000 claims 2
- 235000019441 ethanol Nutrition 0.000 claims 2
- 239000000796 flavoring agent Substances 0.000 claims 2
- 235000019634 flavors Nutrition 0.000 claims 2
- 235000003599 food sweetener Nutrition 0.000 claims 2
- 239000002798 polar solvent Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 claims 2
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 claims 2
- 239000003765 sweetening agent Substances 0.000 claims 2
- 239000006068 taste-masking agent Substances 0.000 claims 2
- 235000006679 Mentha X verticillata Nutrition 0.000 claims 1
- 235000002899 Mentha suaveolens Nutrition 0.000 claims 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims 1
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 claims 1
- 239000004376 Sucralose Substances 0.000 claims 1
- 239000008370 chocolate flavor Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 239000008369 fruit flavor Substances 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 208000002815 pulmonary hypertension Diseases 0.000 claims 1
- 229960002639 sildenafil citrate Drugs 0.000 claims 1
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical group OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims 1
- 235000019408 sucralose Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161566879P | 2011-12-05 | 2011-12-05 | |
| US61/566,879 | 2011-12-05 | ||
| PCT/US2012/067763 WO2013085904A1 (en) | 2011-12-05 | 2012-12-04 | Oral spray formulations and methods for administration of sildenafil |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015500285A JP2015500285A (ja) | 2015-01-05 |
| JP2015500285A5 true JP2015500285A5 (enExample) | 2015-11-19 |
| JP6047174B2 JP6047174B2 (ja) | 2016-12-21 |
Family
ID=47430090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014545981A Expired - Fee Related JP6047174B2 (ja) | 2011-12-05 | 2012-12-04 | シルデナフィルの経口スプレー製剤及びその投与方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9186321B2 (enExample) |
| EP (1) | EP2787967B1 (enExample) |
| JP (1) | JP6047174B2 (enExample) |
| KR (1) | KR20140117360A (enExample) |
| CN (1) | CN104822368B (enExample) |
| AU (1) | AU2012347997B2 (enExample) |
| BR (1) | BR112014013650A2 (enExample) |
| CA (1) | CA2858364C (enExample) |
| IL (1) | IL232970A0 (enExample) |
| RU (1) | RU2611403C1 (enExample) |
| SG (1) | SG11201402938RA (enExample) |
| WO (1) | WO2013085904A1 (enExample) |
| ZA (1) | ZA201404091B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015070049A1 (en) * | 2013-11-08 | 2015-05-14 | Insys Pharma, Inc. | Sildenafil sublingual spray formulation |
| NO2723977T3 (enExample) | 2014-03-19 | 2018-03-10 | ||
| US10111833B2 (en) | 2015-04-03 | 2018-10-30 | Insys Development Company, Inc. | Sildenafil sublingual spray formulations |
| DK3277283T3 (da) * | 2015-04-03 | 2021-04-12 | Benuvia Therapeutics Llc | Sublinguale sildenafilsprayformuerlinger |
| BR102015020720A2 (pt) * | 2015-08-27 | 2017-03-01 | Henrique Leonardo Pereira Luis | composição hidrofíilica atóxica, bioidêntica e biodegradável à base de partículas micronizadas de acido hialurônico, com propriedades mucoadesivas e carreadoras via transmucosa aglutinadas por bioengenharia a um ipde5, para tratamento de disfunção erétil, com aplicação em sistema de spray de aerossol sublingual |
| WO2018070971A1 (ru) * | 2016-10-10 | 2018-04-19 | Товарыство З Обмэжэною Видповидальнистю Науково-Выробныча Фирма "Микрохим" | Фармацевтическая композиция в форме оромукозного спрея для лечения эректильной дисфункции и легочной артериальной гипертензии |
| KR20190082803A (ko) * | 2016-10-31 | 2019-07-10 | 수다 리미티드 | 점막의 활성 제제 전달 |
| JP2023502004A (ja) * | 2019-11-07 | 2023-01-20 | ノヴォ ノルディスク アー／エス | Ｇｌｐ－１作動薬、ｓｇｌｔ２阻害剤、およびｎ－（８－（２－ヒドロキシベンゾイル）アミノ）カプリル酸の塩を含む固形組成物 |
| CN111110633B (zh) * | 2020-01-21 | 2022-12-02 | 合肥医工医药股份有限公司 | 一种他达拉非喷雾剂及其制备方法 |
| KR20230129017A (ko) * | 2020-12-04 | 2023-09-05 | 타이그러스, 엘엘씨 | 호흡기 병을 갖는 환자를 다루기 위한 적어도 하나의병원균에 활성인 낮은 pH 및 낮은 독성을 갖는 치료 물질 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030077229A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| US20030082107A1 (en) * | 1997-10-01 | 2003-05-01 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| DE19834506A1 (de) | 1998-07-31 | 2000-02-03 | Hexal Ag | Transmucosales therapeutisches System zur Anwendung von Sildenafil |
| EP1140027B1 (en) * | 1998-12-23 | 2005-10-12 | Alza Corporation | Dosage forms comprising porous particles |
| IL139454A0 (en) * | 1999-11-08 | 2001-11-25 | Pfizer | Compounds for the treatment of female sexual dysfunction |
| AU3048501A (en) * | 1999-11-18 | 2001-05-30 | Natco Pharma Limited | An improved pharmaceutical composition for treating male erectile dysfunction |
| CN1277021A (zh) * | 2000-06-20 | 2000-12-20 | 王建华 | 一种治疗阳痿病的喷雾剂药物及其制备方法 |
| DE10248601B4 (de) * | 2002-10-17 | 2006-05-24 | Goldstein, Naum, Dr.habil.nat. | Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems |
| US7554270B2 (en) * | 2003-05-28 | 2009-06-30 | Tokyo Ohka Kogyo Co., Ltd. | Composition for dielectric of plasma display panel, laminate for dielectric, and method for forming the dielectric |
| WO2005077374A1 (en) * | 2004-02-06 | 2005-08-25 | Becton, Dickinson And Company | Formulations of phosphodiesterase 5 inhibitors and methods of use |
| KR20070057829A (ko) * | 2004-08-23 | 2007-06-07 | 맨카인드 코포레이션 | 포스포디에스테라아제 5형의 억제제의 폐 전달 |
| EP1898879A1 (en) | 2005-06-23 | 2008-03-19 | Schering Corporation | Rapidly absorbing oral formulations of pde5 inhibitors |
| AU2007204208A1 (en) * | 2006-01-11 | 2007-07-19 | Astrazeneca Ab | Morpholino pyrimidine derivatives and their use in therapy |
| US20090317461A1 (en) * | 2006-08-02 | 2009-12-24 | Wm. Wrigley Jr. Company | Oral compositions effective for the treatment of oral cavity malodor associated with the consumption of odor-causing compounds |
| JP5686978B2 (ja) * | 2009-03-18 | 2015-03-18 | 第一三共ヘルスケア株式会社 | シルデナフィルクエン酸塩含有内服液剤及びその液剤含有容器 |
-
2012
- 2012-12-04 RU RU2014123435A patent/RU2611403C1/ru not_active IP Right Cessation
- 2012-12-04 BR BR112014013650A patent/BR112014013650A2/pt not_active Application Discontinuation
- 2012-12-04 EP EP12806256.9A patent/EP2787967B1/en active Active
- 2012-12-04 JP JP2014545981A patent/JP6047174B2/ja not_active Expired - Fee Related
- 2012-12-04 CN CN201280068898.5A patent/CN104822368B/zh not_active Expired - Fee Related
- 2012-12-04 KR KR1020147016435A patent/KR20140117360A/ko not_active Ceased
- 2012-12-04 WO PCT/US2012/067763 patent/WO2013085904A1/en not_active Ceased
- 2012-12-04 AU AU2012347997A patent/AU2012347997B2/en not_active Ceased
- 2012-12-04 SG SG11201402938RA patent/SG11201402938RA/en unknown
- 2012-12-04 US US14/363,245 patent/US9186321B2/en not_active Expired - Fee Related
- 2012-12-04 CA CA2858364A patent/CA2858364C/en not_active Expired - Fee Related
-
2014
- 2014-06-05 IL IL232970A patent/IL232970A0/en unknown
- 2014-06-05 ZA ZA2014/04091A patent/ZA201404091B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015500285A5 (enExample) | ||
| JP2011502997A5 (enExample) | ||
| EP3003384B1 (en) | Oral solution comprising atomoxetine hydrochloride | |
| JP2014515373A5 (enExample) | ||
| US20080280947A1 (en) | Anti-insomnia compositions and methods | |
| RU2014101990A (ru) | Жидкая фармацевтическая композиция, включающая нитизинон | |
| KR101365458B1 (ko) | 구강 투여용 아포모르핀의 약제학적 제형 | |
| EP3013323A2 (en) | Complex granule formulation having improved stability comprising levocetirizine and montelukast | |
| CN113242736A (zh) | 一种治疗肺动脉高压和相关性肺动脉高压的方法 | |
| US9326935B2 (en) | Atomoxetine solution | |
| JP2023506545A (ja) | アゴメラチンを含有する経粘膜治療システム | |
| JP5992171B2 (ja) | 上気道の疾患およびインフルエンザ症候群を治療するための組成物 | |
| CN113784717A (zh) | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 | |
| EP3236949B1 (en) | Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof | |
| JP2002348236A (ja) | 医薬液剤 | |
| JPWO2019232130A5 (enExample) | ||
| CA2894466A1 (en) | Uses and methods for the treatment of liver diseases or conditions | |
| WO2016102708A1 (en) | Oral topical aqueous pharmaceutical compositions of flurbiprofen and dexpanthenol | |
| JP2014511850A5 (enExample) | ||
| JP2008535907A5 (enExample) | ||
| JP2005162713A (ja) | 内服用組成物 | |
| JP2004091420A (ja) | 内服用医薬組成物 | |
| AU2013384129B2 (en) | Oral suspension for treating eosinophilic esophagitis | |
| JP6875747B2 (ja) | 生薬成分を含む肺高血圧症の予防又は治療剤 | |
| JP2009507850A5 (enExample) |